首页 > 最新文献

European Journal of Integrative Medicine最新文献

英文 中文
Efficacy, safety, and pharmacological mechanism of Suxiao Jiuxin Pill in acute coronary syndrome: A systematic review and network pharmacology analysis 素消九心丸治疗急性冠脉综合征的疗效、安全性及药理机制:系统评价及网络药理学分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-02 DOI: 10.1016/j.eujim.2025.102524
Xinyue Hu , Yaoyuan Liu , Opoku Bonsu Francis , Jingwen Guo , Huiwen Feng , Ruiqiao Li , Ling Leng , Wentai Pang , Qilong Wang

Introduction

Suxiao Jiuxin Pill (SJP), a patented Chinese medicine, is used to treat various cardiovascular diseases, including acute coronary syndrome (ACS). Nonetheless, substantial evidence validating the efficacy and safety of SJP, as well as elucidating its underlying mechanisms in ACS treatment, is lacking. In this study, a systematic review and network pharmacology approach were employed to evaluate the efficacy and safety of combining SJP with conventional treatment (CT) for ACS and to explore the potential mechanisms.

Methods

A systematic search of eight electronic databases was conducted to retrieve relevant randomized controlled trials (RCTs) which evaluated the efficacy and safety of SJP combined with CT for treating ACS. The Cochrane risk-of-bias tool for RCTs version 2.0 was used to assess the risk of bias. The fixed-effects model or the random-effects model was determined based on the significance of the statistical heterogeneity and clinical heterogeneity. Risk ratios and mean differences were calculated for binary variables and continuous variables, respectively, based on a 95 % confidence interval. Finally, network pharmacology analysis was used to explore the underlying mechanisms of action of SJP in ACS treatment.

Results

A total of 39 RCTs involving 4265 patients were included. The intervention group showed significant improvements, including a lower incidence of myocardial infarction, left heart failure, and sudden death, compared to the control group. The intervention group also demonstrated enhanced clinical efficacy, improved electrocardiogram results, fewer angina attacks, and shorter duration of angina. No significant differences in the incidence of adverse events were found between the intervention and control groups. Network pharmacology identified ferulic acid, caffeic acid, and scopoletin as the active ingredients responsible for the observed therapeutic effects of SJP. Additionally, potential therapeutic targets such as GSK3B, PRKCA, and EGFR, as well as other pathways related to the HIF-1, IL-17, and TNF signaling pathways, were identified as potential mechanisms regulated by SJP.

Conclusion

This study indicates that a combination therapy of SJP and CT may provide benefits for patients with ACS by reducing cardiovascular events, improving myocardial ischemia, and alleviating cardiac symptoms with favorable safety. These findings also suggest that the effects of SJP on ACS involve a multi-target, multi-component, and multi-pathway mechanism.
速效九心丸(SJP)是一种中药专利,用于治疗各种心血管疾病,包括急性冠脉综合征(ACS)。尽管如此,尚缺乏足够的证据来证实SJP的有效性和安全性,以及阐明其在ACS治疗中的潜在机制。本研究采用系统评价和网络药理学方法评价SJP联合常规治疗(CT)治疗ACS的疗效和安全性,并探讨其潜在机制。方法系统检索8个电子数据库,检索评价SJP联合CT治疗ACS疗效和安全性的相关随机对照试验(rct)。采用Cochrane rct风险偏倚工具2.0版评估偏倚风险。根据统计异质性和临床异质性的显著性确定固定效应模型或随机效应模型。基于95%的置信区间,分别计算二元变量和连续变量的风险比和平均差异。最后,通过网络药理学分析探讨SJP治疗ACS的作用机制。结果共纳入39项随机对照试验,共4265例患者。与对照组相比,干预组表现出显著的改善,包括心肌梗死、左心衰竭和猝死的发生率较低。干预组临床疗效增强,心电图结果改善,心绞痛发作次数减少,心绞痛持续时间缩短。干预组和对照组的不良事件发生率无显著差异。网络药理学鉴定阿魏酸、咖啡酸和东莨菪碱是导致SJP治疗效果的有效成分。此外,潜在的治疗靶点,如GSK3B、PRKCA和EGFR,以及与HIF-1、IL-17和TNF信号通路相关的其他途径,被确定为SJP调节的潜在机制。结论SJP联合CT治疗ACS患者可减少心血管事件,改善心肌缺血,缓解心脏症状,且安全性较好。这些发现还表明,SJP对ACS的影响涉及多靶点、多组分和多途径机制。
{"title":"Efficacy, safety, and pharmacological mechanism of Suxiao Jiuxin Pill in acute coronary syndrome: A systematic review and network pharmacology analysis","authors":"Xinyue Hu ,&nbsp;Yaoyuan Liu ,&nbsp;Opoku Bonsu Francis ,&nbsp;Jingwen Guo ,&nbsp;Huiwen Feng ,&nbsp;Ruiqiao Li ,&nbsp;Ling Leng ,&nbsp;Wentai Pang ,&nbsp;Qilong Wang","doi":"10.1016/j.eujim.2025.102524","DOIUrl":"10.1016/j.eujim.2025.102524","url":null,"abstract":"<div><h3>Introduction</h3><div>Suxiao Jiuxin Pill (SJP), a patented Chinese medicine, is used to treat various cardiovascular diseases, including acute coronary syndrome (ACS). Nonetheless, substantial evidence validating the efficacy and safety of SJP, as well as elucidating its underlying mechanisms in ACS treatment, is lacking. In this study, a systematic review and network pharmacology approach were employed to evaluate the efficacy and safety of combining SJP with conventional treatment (CT) for ACS and to explore the potential mechanisms.</div></div><div><h3>Methods</h3><div>A systematic search of eight electronic databases was conducted to retrieve relevant randomized controlled trials (RCTs) which evaluated the efficacy and safety of SJP combined with CT for treating ACS. The Cochrane risk-of-bias tool for RCTs version 2.0 was used to assess the risk of bias. The fixed-effects model or the random-effects model was determined based on the significance of the statistical heterogeneity and clinical heterogeneity. Risk ratios and mean differences were calculated for binary variables and continuous variables, respectively, based on a 95 % confidence interval. Finally, network pharmacology analysis was used to explore the underlying mechanisms of action of SJP in ACS treatment.</div></div><div><h3>Results</h3><div>A total of 39 RCTs involving 4265 patients were included. The intervention group showed significant improvements, including a lower incidence of myocardial infarction, left heart failure, and sudden death, compared to the control group. The intervention group also demonstrated enhanced clinical efficacy, improved electrocardiogram results, fewer angina attacks, and shorter duration of angina. No significant differences in the incidence of adverse events were found between the intervention and control groups. Network pharmacology identified ferulic acid, caffeic acid, and scopoletin as the active ingredients responsible for the observed therapeutic effects of SJP. Additionally, potential therapeutic targets such as GSK3B, PRKCA, and EGFR, as well as other pathways related to the HIF-1, IL-17, and TNF signaling pathways, were identified as potential mechanisms regulated by SJP.</div></div><div><h3>Conclusion</h3><div>This study indicates that a combination therapy of SJP and CT may provide benefits for patients with ACS by reducing cardiovascular events, improving myocardial ischemia, and alleviating cardiac symptoms with favorable safety. These findings also suggest that the effects of SJP on ACS involve a multi-target, multi-component, and multi-pathway mechanism.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102524"},"PeriodicalIF":1.9,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Tai Chi and resistance exercise on fatigue in patients with ulcerative colitis: A randomized clinical trial 太极拳和抗阻运动对溃疡性结肠炎患者疲劳的影响:一项随机临床试验
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-29 DOI: 10.1016/j.eujim.2025.102519
Yu Zhou , Tengteng Ding , Ranran Qiao , Ping Zhang , Hui Li , Qiong Liu

Introduction

Fatigue is common and burdensome in patients with ulcerative colitis (UC), yet pharmacological treatments offer limited relief. Exercise is gaining attention as a non-pharmacological strategy, and resistance training is increasingly recommended. However, Tai Chi—a traditional Chinese exercise—has not yet been evaluated in this population. This study compared the effects of Tai Chi and resistance training on multiple outcomes in patients with UC.

Methods

This single-center, evaluator-blind, three-arm randomized clinical trial block-randomized 75 patients with UC to 12 weeks of Tai Chi or resistance training and a control group involving standard treatment and care with general exercise advice. Eligible participants had fatigue (Multidimensional Fatigue Inventory score ≥ 40) and were in remission or had mild-to-moderate disease activity (Modified Mayo score ≤ 10). The primary outcome was fatigue, secondary outcomes included handgrip strength (HGS), skeletal muscle mass index (SMI), sleep quality, anxiety, depression, and health-related quality of life, all strongly associated with fatigue.

Results

The three groups showed significant differences in total fatigue and in general, physical, and mental fatigue subdimensions. Compared with the control group, fatigue improved in both the Tai Chi group (mean difference:8.90 [95 % confidence interval [CI], -15.11 to -2.69]) and the resistance training group (mean difference:7.00 [95 % CI, -13.16 to -0.84]), with no significant differences between them. However, between the two interventions, Tai Chi showed numerically greater improvements in anxiety, depression, and emotional function, while resistance training led to greater improvements in HGS (mean difference: 7.50 [95 % CI, 2.37 to 12.63]) and SMI (mean difference: 0.54 [95 % CI, 0.01 to 1.08]). No adverse events occurred, except for one case of mild abdominal discomfort in the resistance training group, which resolved with rest.

Conclusions

Both Tai Chi and resistance training effectively reduced fatigue and improved related outcomes in UC patients. Tai Chi may be more beneficial for psychological symptoms, while resistance training showed greater improvements in physical strength. Given their complementary advantages and safety, both may serve as valuable non-pharmacological options in UC management. Future studies should explore their integration into long-term, multimodal treatment strategies.

Registration

ChiCTR2300071289.

Funding

None.
在溃疡性结肠炎(UC)患者中,疲劳是常见且令人难以忍受的,但药物治疗提供的缓解有限。运动作为一种非药物策略正受到越来越多的关注,阻力训练也越来越被推荐。然而,太极拳——一种中国传统运动——尚未在这一人群中得到评估。本研究比较了太极拳和阻力训练对UC患者多种预后的影响。这项单中心、评估盲、三组随机临床试验将75名UC患者随机分为12周的太极或阻力训练,对照组包括标准治疗和护理,并提供一般运动建议。符合条件的参与者有疲劳(多维疲劳量表评分≥40),缓解或有轻至中度疾病活动(改良梅奥评分≤10)。主要结局是疲劳,次要结局包括握力(HGS)、骨骼肌质量指数(SMI)、睡眠质量、焦虑、抑郁和健康相关生活质量,这些都与疲劳密切相关。结果三组在总疲劳、一般疲劳、身体疲劳和精神疲劳维度上均存在显著差异。与对照组相比,太极拳组(平均差异:8.90[95%可信区间[CI], -15.11至-2.69])和阻力训练组(平均差异:7.00[95%可信区间[CI], -13.16至-0.84])的疲劳有所改善,两者之间无显著差异。然而,在两种干预措施之间,太极拳在焦虑、抑郁和情绪功能方面表现出更大的改善,而阻力训练在HGS(平均差异:7.50 [95% CI, 2.37至12.63])和SMI(平均差异:0.54 [95% CI, 0.01至1.08])方面表现出更大的改善。除阻力训练组有1例腹部轻度不适外,其他不良事件均未发生。结论太极拳和阻力训练均能有效减轻UC患者的疲劳,改善相关预后。太极拳可能对心理症状更有益,而阻力训练对体力的改善更大。鉴于它们的互补优势和安全性,两者都可以作为UC管理中有价值的非药物选择。未来的研究应探索它们与长期、多模式治疗策略的结合。
{"title":"Effects of Tai Chi and resistance exercise on fatigue in patients with ulcerative colitis: A randomized clinical trial","authors":"Yu Zhou ,&nbsp;Tengteng Ding ,&nbsp;Ranran Qiao ,&nbsp;Ping Zhang ,&nbsp;Hui Li ,&nbsp;Qiong Liu","doi":"10.1016/j.eujim.2025.102519","DOIUrl":"10.1016/j.eujim.2025.102519","url":null,"abstract":"<div><h3>Introduction</h3><div>Fatigue is common and burdensome in patients with ulcerative colitis (UC), yet pharmacological treatments offer limited relief. Exercise is gaining attention as a non-pharmacological strategy, and resistance training is increasingly recommended. However, Tai Chi—a traditional Chinese exercise—has not yet been evaluated in this population. This study compared the effects of Tai Chi and resistance training on multiple outcomes in patients with UC.</div></div><div><h3>Methods</h3><div>This single-center, evaluator-blind, three-arm randomized clinical trial block-randomized 75 patients with UC to 12 weeks of Tai Chi or resistance training and a control group involving standard treatment and care with general exercise advice. Eligible participants had fatigue (Multidimensional Fatigue Inventory score ≥ 40) and were in remission or had mild-to-moderate disease activity (Modified Mayo score ≤ 10). The primary outcome was fatigue, secondary outcomes included handgrip strength (HGS), skeletal muscle mass index (SMI), sleep quality, anxiety, depression, and health-related quality of life, all strongly associated with fatigue.</div></div><div><h3>Results</h3><div>The three groups showed significant differences in total fatigue and in general, physical, and mental fatigue subdimensions. Compared with the control group, fatigue improved in both the Tai Chi group (mean difference:8.90 [95 % confidence interval [CI], -15.11 to -2.69]) and the resistance training group (mean difference:7.00 [95 % CI, -13.16 to -0.84]), with no significant differences between them. However, between the two interventions, Tai Chi showed numerically greater improvements in anxiety, depression, and emotional function, while resistance training led to greater improvements in HGS (mean difference: 7.50 [95 % CI, 2.37 to 12.63]) and SMI (mean difference: 0.54 [95 % CI, 0.01 to 1.08]). No adverse events occurred, except for one case of mild abdominal discomfort in the resistance training group, which resolved with rest.</div></div><div><h3>Conclusions</h3><div>Both Tai Chi and resistance training effectively reduced fatigue and improved related outcomes in UC patients. Tai Chi may be more beneficial for psychological symptoms, while resistance training showed greater improvements in physical strength. Given their complementary advantages and safety, both may serve as valuable non-pharmacological options in UC management. Future studies should explore their integration into long-term, multimodal treatment strategies.</div></div><div><h3>Registration</h3><div>ChiCTR2300071289.</div></div><div><h3>Funding</h3><div>None.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102519"},"PeriodicalIF":1.9,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144663599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal protective effects of Tongxinluo capsule for hypertensive nephropathy: A systematic review and meta-analysis 通心络胶囊对高血压肾病的肾保护作用:系统综述和荟萃分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-27 DOI: 10.1016/j.eujim.2025.102521
Xuan Song , Xinkang Li , Luda Feng , Xinyi Shi , Rufan Xu , Ning Liang , Boyang Li , Boya Zhang , Jianguo Qin

Introduction

Hypertensive nephropathy (HN) remains the second leading cause of end-stage renal disease. Tongxinluo capsule is commonly used in the treatment of HN under the condition that there is no specific therapy. We aimed to assess the efficacy and safety of Tongxinluo capsule for HN.

Methods

We systematically searched Pubmed, Embase, the Cochrane Library, China National Knowledge Infrastructure, Chinese Scientific Journals Database of VIP INFORMATION, Wanfang Data, and SinoMed from their inception to December 2024. Randomized controlled trials (RCTs) comparing the efficacy of Tongxinluo capsule versus placebo or no specific therapy based on usual care among patients with hypertensive nephropathy were included. Study selection and data extraction were independently conducted by two reviewers. The primary outcome was 24-hour urine protein, and secondary outcomes include the level of urinary β2-microglobulin, creatinine clearance rate, serum creatinine, systolic blood pressure, and diastolic blood pressure. In terms of safety, the incidence of adverse events was the main indicator. A fixed-effects model or random-effects model was used when applicable. A 2-tailed p<0.05 was considered statistically significant.

Results

Eight RCTs (742 participants) were included in our study. The quantitative synthesis showed that Tongxinluo capsule could significantly reduce 24-hour proteinuria (MD, -0.11; 95 % CI, -0.20 to -0.02) and urinary β2-microglobulin (MD, -244.26; 95 % CI, -463.50 to -25.01), and slightly increase creatinine clearance rate (MD, 2.28; 95 % CI, 0.42 to 4.14). No significant differences were observed in decreasing serum creatinine (MD, -8.82; 95 % CI, -18.00 to 0.36), or antihypertensive effect (systolic blood pressure [MD, -2.18; 95 % CI, -5.98 to 1.63]; diastolic blood pressure [MD, -2.55; 95 % CI -6.03 to 0.92]). There are no obvious anomalies in terms of adverse events.

Conclusion

This is currently the first systematic review to provide up-to-date evidence regarding the Tongxinluo capsule treatment profile in HN. Based on the available RCTs, Tongxinluo capsule showed promising renal protective benefits in reducing proteinuria levels, and could be a therapeutic option for HN. High-quality studies are needed to further verify our findings.

Protocol registration

PROSPERO (CRD42023484654).
高血压肾病(HN)仍然是终末期肾脏疾病的第二大原因。通心络胶囊在没有特效药的情况下,常用于治疗HN。目的是评价通心络胶囊治疗HN的疗效和安全性。方法系统检索Pubmed、Embase、Cochrane图书馆、中国国家知识基础设施、中国科学期刊数据库VIP信息、万方数据、中国医学信息数据库自成立至2024年12月的数据库。随机对照试验(rct)比较通心络胶囊与安慰剂或基于常规护理的无特异性治疗对高血压肾病患者的疗效。研究选择和数据提取由两名审稿人独立进行。主要终点是24小时尿蛋白,次要终点包括尿β2-微球蛋白水平、肌酐清除率、血清肌酐、收缩压和舒张压。在安全性方面,不良事件发生率是主要指标。适用时采用固定效应模型或随机效应模型。双尾p<;0.05被认为具有统计学意义。结果共纳入8项随机对照试验(rct),共742名受试者。定量合成表明通心络胶囊可显著降低24小时蛋白尿(MD, -0.11;95% CI, -0.20 ~ -0.02)和尿β2微球蛋白(MD, -244.26;95% CI, -463.50 ~ -25.01),肌酐清除率略有增加(MD, 2.28;95% CI, 0.42 - 4.14)。血清肌酐(MD, -8.82;95% CI, -18.00 - 0.36),或降压效果(收缩压[MD, -2.18;95% CI, -5.98 ~ 1.63];舒张压[MD, -2.55;95% CI -6.03 ~ 0.92])。在不良事件方面没有明显的异常。结论:本研究为通心络胶囊治疗HN提供了最新的系统评价。根据现有的随机对照试验,通心络胶囊在降低蛋白尿水平方面显示出良好的肾保护作用,可能是HN的治疗选择。需要高质量的研究来进一步验证我们的发现。协议注册prospero (CRD42023484654)。
{"title":"Renal protective effects of Tongxinluo capsule for hypertensive nephropathy: A systematic review and meta-analysis","authors":"Xuan Song ,&nbsp;Xinkang Li ,&nbsp;Luda Feng ,&nbsp;Xinyi Shi ,&nbsp;Rufan Xu ,&nbsp;Ning Liang ,&nbsp;Boyang Li ,&nbsp;Boya Zhang ,&nbsp;Jianguo Qin","doi":"10.1016/j.eujim.2025.102521","DOIUrl":"10.1016/j.eujim.2025.102521","url":null,"abstract":"<div><h3>Introduction</h3><div>Hypertensive nephropathy (HN) remains the second leading cause of end-stage renal disease. Tongxinluo capsule is commonly used in the treatment of HN under the condition that there is no specific therapy. We aimed to assess the efficacy and safety of Tongxinluo capsule for HN.</div></div><div><h3>Methods</h3><div>We systematically searched Pubmed, Embase, the Cochrane Library, China National Knowledge Infrastructure, Chinese Scientific Journals Database of VIP INFORMATION, Wanfang Data, and SinoMed from their inception to December 2024. Randomized controlled trials (RCTs) comparing the efficacy of Tongxinluo capsule versus placebo or no specific therapy based on usual care among patients with hypertensive nephropathy were included. Study selection and data extraction were independently conducted by two reviewers. The primary outcome was 24-hour urine protein, and secondary outcomes include the level of urinary β2-microglobulin, creatinine clearance rate, serum creatinine, systolic blood pressure, and diastolic blood pressure. In terms of safety, the incidence of adverse events was the main indicator. A fixed-effects model or random-effects model was used when applicable. A 2-tailed p&lt;0.05 was considered statistically significant.</div></div><div><h3>Results</h3><div>Eight RCTs (742 participants) were included in our study. The quantitative synthesis showed that Tongxinluo capsule could significantly reduce 24-hour proteinuria (MD, -0.11; 95 % CI, -0.20 to -0.02) and urinary β2-microglobulin (MD, -244.26; 95 % CI, -463.50 to -25.01), and slightly increase creatinine clearance rate (MD, 2.28; 95 % CI, 0.42 to 4.14). No significant differences were observed in decreasing serum creatinine (MD, -8.82; 95 % CI, -18.00 to 0.36), or antihypertensive effect (systolic blood pressure [MD, -2.18; 95 % CI, -5.98 to 1.63]; diastolic blood pressure [MD, -2.55; 95 % CI -6.03 to 0.92]). There are no obvious anomalies in terms of adverse events.</div></div><div><h3>Conclusion</h3><div>This is currently the first systematic review to provide up-to-date evidence regarding the Tongxinluo capsule treatment profile in HN. Based on the available RCTs, Tongxinluo capsule showed promising renal protective benefits in reducing proteinuria levels, and could be a therapeutic option for HN. High-quality studies are needed to further verify our findings.</div></div><div><h3>Protocol registration</h3><div>PROSPERO (CRD42023484654).</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102521"},"PeriodicalIF":1.9,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144653322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of yoga and naturopathy in the management of melasma: A case report 瑜伽和自然疗法在黄褐斑治疗中的作用:1例报告
IF 1.7 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-27 DOI: 10.1016/j.eujim.2025.102522
Sunil Singh Yadav , Rita Thapa , Sangeeth Somanadhapai , Deepeshwar Singh

Introduction

Melasma is a common dermatological condition characterized by hyperpigmentation patches, often caused by hormonal imbalance, oxidative stress, and sun exposure. Conventional interventions usually have limited efficacy and may cause side effects. This case report explores the potential of traditional therapies in managing melasma, specifically yoga and naturopathy, which can enhance natural healing.

Case Presentation

A 27-year-old female diagnosed with persistent melasma visited a yoga and naturopathy center for the interventions. The patient was treated with a structured intervention protocol, including yogic-based breathing, dietary changes, and mud pack. The effect of this intervention was evaluated using Melasma Area Severity Index (MASI) and Melasma Quality of Life Scale (MELASQOL). After 60 days of intervention, MASI score improved by 85.12 %, and MELASQOL score improved by 75 %, indicating significant improvement in the clinical and quality of life questionnaires.

Conclusion

This case highlights the potential effectiveness of yoga and naturopathy in managing melasma. The positive outcome supports the role of traditional therapies in clinical practice; however, further research with larger sample sizes is required to confirm these findings.
黄褐斑是一种常见的皮肤疾病,以色素沉着斑块为特征,通常由激素失衡、氧化应激和日晒引起。传统的干预措施通常效果有限,并可能引起副作用。本病例报告探讨了管理黄褐斑的传统疗法的潜力,特别是瑜伽和自然疗法,可以增强自然愈合。病例介绍一名27岁女性,诊断为持续性黄褐斑,前往瑜伽和自然疗法中心进行干预。患者采用结构化干预方案进行治疗,包括以瑜伽为基础的呼吸、饮食改变和泥敷。采用黄褐斑面积严重指数(MASI)和黄褐斑生活质量量表(MELASQOL)评估干预效果。干预60天后,MASI评分提高85.12 %,MELASQOL评分提高75 %,临床和生活质量问卷均有显著改善。结论本病例强调了瑜伽和自然疗法治疗黄褐斑的潜在有效性。积极的结果支持传统疗法在临床实践中的作用;然而,需要更大样本量的进一步研究来证实这些发现。
{"title":"Effect of yoga and naturopathy in the management of melasma: A case report","authors":"Sunil Singh Yadav ,&nbsp;Rita Thapa ,&nbsp;Sangeeth Somanadhapai ,&nbsp;Deepeshwar Singh","doi":"10.1016/j.eujim.2025.102522","DOIUrl":"10.1016/j.eujim.2025.102522","url":null,"abstract":"<div><h3>Introduction</h3><div>Melasma is a common dermatological condition characterized by hyperpigmentation patches, often caused by hormonal imbalance, oxidative stress, and sun exposure. Conventional interventions usually have limited efficacy and may cause side effects. This case report explores the potential of traditional therapies in managing melasma, specifically yoga and naturopathy, which can enhance natural healing.</div></div><div><h3>Case Presentation</h3><div>A 27-year-old female diagnosed with persistent melasma visited a yoga and naturopathy center for the interventions. The patient was treated with a structured intervention protocol, including yogic-based breathing, dietary changes, and mud pack. The effect of this intervention was evaluated using Melasma Area Severity Index (MASI) and Melasma Quality of Life Scale (MELASQOL). After 60 days of intervention, MASI score improved by 85.12 %, and MELASQOL score improved by 75 %, indicating significant improvement in the clinical and quality of life questionnaires.</div></div><div><h3>Conclusion</h3><div>This case highlights the potential effectiveness of yoga and naturopathy in managing melasma. The positive outcome supports the role of traditional therapies in clinical practice; however, further research with larger sample sizes is required to confirm these findings.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"79 ","pages":"Article 102522"},"PeriodicalIF":1.7,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144763606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing the utilization of traditional Korean medicine and continuity of care among individuals with disabilities in Korea: A cross-sectional analysis using national health insurance data 影响韩国传统医学使用和韩国残疾人护理连续性的因素:使用国家健康保险数据的横断面分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-25 DOI: 10.1016/j.eujim.2025.102520
Ji-eun Yu , Hyunmin Kim , Chihyoung Son , Eunji Ahn , Dongsu Kim

Introduction

In South Korea, under a dual healthcare system, both Western and traditional Korean medicine (TKM) play a role in managing the health of individuals with disabilities. This study aimed to identify various factors influencing TKM utilization by individuals with disabilities and the continuity of TKM care.

Methods

Data from the “Sample Cohort Database” of the National Health Insurance Service were used, focusing on 55,876 individuals registered as persons with disabilities. Multinomial logistic regression analysis was conducted to identify the factors associated with TKM utilization and the level of continuity of outpatient care in TKM, as measured by TKM Continuity of Care Index (TKM-COCI), among individuals with disabilities.

Results

This study included 53,444 registered individuals with disabilities. The entire cohort was analyzed for factors influencing TKM utilization, while a subset of 16,330 individuals with prior TKM experience was examined for factors affecting continuity of TKM. Analysis of TKM utilization patterns by disability type revealed that, for all disability types, individuals with musculoskeletal disorders had the highest proportion of TKM utilization, with a higher frequency of utilization observed for mild conditions than for severe conditions. Variables affecting both TKM utilization and TKM-COCI for individuals with disabilities included sex, long-term care insurance for the elderly, household income, severity and the Charlson Comorbidity Index. TKM utilization was lower among men, individuals with long-term care insurance, medical aid recipients, those without comorbidities, and individuals with severe disabilities; however, the probability of having a high TKM-COCI was higher in these cases.

Conclusions

It was found that the trends in TKM utilization and TKM-COCI showed opposing patterns according to the severity of disability and CCI. This suggests that the primary purpose of TKM utilization among individuals with disabilities is to prevent or manage the exacerbation of symptoms. Further investigation is needed to clarify this relationship.

Funding

No funding was received for this study.
在韩国,在双重医疗体系下,西方和传统的韩国医学(TKM)在管理残疾人的健康方面发挥着作用。本研究旨在探讨影响残障人士TKM使用及TKM照护连续性的各种因素。方法采用国民健康保险服务“样本队列数据库”中的数据,以登记为残疾人的55,876人为研究对象。采用多项logistic回归分析确定与TKM利用相关的因素和TKM门诊护理的连续性水平,以TKM护理连续性指数(TKM- coci)衡量,在残疾人中。结果本研究共纳入53,444名登记残障人士。分析了整个队列中影响TKM利用的因素,同时对16,330名有TKM经验的个体进行了检查,以确定影响TKM连续性的因素。对残疾类型的TKM利用模式分析显示,在所有残疾类型中,肌肉骨骼疾病患者的TKM利用比例最高,轻度疾病患者的TKM利用频率高于重度疾病患者。影响残障人士TKM使用率和TKM- coci的变量包括性别、老年人长期护理保险、家庭收入、严重程度和Charlson合并症指数。男性、有长期护理保险的个体、医疗援助接受者、无合并症的个体和重度残疾个体的TKM利用率较低;然而,在这些病例中,具有高TKM-COCI的可能性更高。结论残障患者TKM利用率和TKM- coci随残障严重程度和CCI的变化趋势相反。这表明残疾人使用TKM的主要目的是预防或控制症状的恶化。需要进一步的调查来澄清这种关系。本研究未收到任何资金。
{"title":"Factors influencing the utilization of traditional Korean medicine and continuity of care among individuals with disabilities in Korea: A cross-sectional analysis using national health insurance data","authors":"Ji-eun Yu ,&nbsp;Hyunmin Kim ,&nbsp;Chihyoung Son ,&nbsp;Eunji Ahn ,&nbsp;Dongsu Kim","doi":"10.1016/j.eujim.2025.102520","DOIUrl":"10.1016/j.eujim.2025.102520","url":null,"abstract":"<div><h3>Introduction</h3><div>In South Korea, under a dual healthcare system, both Western and traditional Korean medicine (TKM) play a role in managing the health of individuals with disabilities. This study aimed to identify various factors influencing TKM utilization by individuals with disabilities and the continuity of TKM care.</div></div><div><h3>Methods</h3><div>Data from the “Sample Cohort Database” of the National Health Insurance Service were used, focusing on 55,876 individuals registered as persons with disabilities. Multinomial logistic regression analysis was conducted to identify the factors associated with TKM utilization and the level of continuity of outpatient care in TKM, as measured by TKM Continuity of Care Index (TKM-COCI), among individuals with disabilities.</div></div><div><h3>Results</h3><div>This study included 53,444 registered individuals with disabilities. The entire cohort was analyzed for factors influencing TKM utilization, while a subset of 16,330 individuals with prior TKM experience was examined for factors affecting continuity of TKM. Analysis of TKM utilization patterns by disability type revealed that, for all disability types, individuals with musculoskeletal disorders had the highest proportion of TKM utilization, with a higher frequency of utilization observed for mild conditions than for severe conditions. Variables affecting both TKM utilization and TKM-COCI for individuals with disabilities included sex, long-term care insurance for the elderly, household income, severity and the Charlson Comorbidity Index. TKM utilization was lower among men, individuals with long-term care insurance, medical aid recipients, those without comorbidities, and individuals with severe disabilities; however, the probability of having a high TKM-COCI was higher in these cases.</div></div><div><h3>Conclusions</h3><div>It was found that the trends in TKM utilization and TKM-COCI showed opposing patterns according to the severity of disability and CCI. This suggests that the primary purpose of TKM utilization among individuals with disabilities is to prevent or manage the exacerbation of symptoms. Further investigation is needed to clarify this relationship.</div></div><div><h3>Funding</h3><div>No funding was received for this study.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102520"},"PeriodicalIF":1.9,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144670878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is traditional Chinese medicine syndrome differentiation important in primary insomnia? An exploratory review with matching recombination indirect comparisons and network meta-analysis 中医辨证对原发性失眠重要吗?采用匹配重组、间接比较和网络元分析的探索性综述
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-17 DOI: 10.1016/j.eujim.2025.102515
Guo-Dong Li , Xin-Yu Hu , Yi Yuan , Xi-Jing Meng , Le-Yan Hu , Yu-Ting Huang , Hui-Juan Cao

Introduction

Syndrome differentiation is the primary method of Traditional Chinese Medicine (TCM) diagnosis and treatment of diseases and has become the key to the clinical development of acupuncture. However, there is a lack of supporting clinical evidence to determine the impact of syndrome differentiation on the efficacy of acupuncture treatment. Therefore, we aimed to evaluate the importance of point selection based on syndrome differentiation by re-analyzing the trials' results in treating primary insomnia with acupuncture.

Methods

We systematically searched 9 databases for eligible trials. Two authors extracted data independently from citations, interventions, and outcomes. Since the "treatment acupuncture" and "control acupuncture" data compared in this study were from different trials, we matched the data in a 1:1 ratio and minimized heterogeneity between the paired groups. Matching factors included age, sex ratio, and the baseline Pittsburgh Sleep Quality Index (PSQI) score. Meta-analyses were performed using Revman 5.4 software. STATA 15.0 was used for the network meta-analysis. Effect estimation presented continuous data with a standard mean difference (SMD) with a 95 % confidence interval (CI).

Results

We included a total of 172 trials. After matching, 19 recombinational pairs of studies were established. Meta-analysis of the 19 pairs showed that PSQI scores in the syndrome differentiation group were lower than the non-syndrome differentiation group (SMD: -0.87, 95 %CI -1.46 to -0.28, P = 0.004). Network meta-analysis of all included trials showed no statistical difference in acupoints selection between syndrome and non-syndrome differentiation (SMD: -0.40, 95 % CI -2.63 to 1.84). However, acupoint selection based on syndrome differentiation (43.9 %) ranks higher than acupoint selection based on non-syndrome differentiation (38.0 %) according to SUCRA curves.

Conclusions

Current evidence does not conclusively support the superiority of syndrome differentiation-based acupuncture over non-syndrome differentiation for primary insomnia. While statistically significant large effect size was observed in matched studies, the clinical relevance of this difference remains uncertain due to methodological limitations, heterogeneity, and inconsistent findings across analytical approaches. Future trials with direct comparisons and standardized outcome measures are needed to clarify the clinical utility of syndrome differentiation in acupuncture therapy.
辨证论治是中医诊断和治疗疾病的主要方法,已成为针灸临床发展的关键。然而,辨证论治对针灸治疗效果的影响,缺乏临床证据的支持。因此,我们旨在通过重新分析针灸治疗原发性失眠的试验结果,评估辨证取穴的重要性。方法系统检索9个数据库,筛选符合条件的试验。两位作者独立地从引文、干预措施和结果中提取数据。由于本研究比较的“治疗针灸”和“对照针灸”数据来自不同的试验,我们以1:1的比例匹配数据,尽量减少配对组之间的异质性。匹配因素包括年龄、性别比例和基线匹兹堡睡眠质量指数(PSQI)得分。采用Revman 5.4软件进行meta分析。采用STATA 15.0进行网络meta分析。效应估计提供了具有95%置信区间(CI)的标准平均差(SMD)的连续数据。结果共纳入172项试验。匹配后,共建立19对重组研究。对19对患者进行meta分析,辨证组PSQI评分低于非辨证组(SMD: -0.87, 95% CI -1.46 ~ -0.28, P = 0.004)。所有纳入试验的网络荟萃分析显示,辨证与非辨证在选穴上无统计学差异(SMD: -0.40, 95% CI -2.63 ~ 1.84)。但根据SUCRA曲线,辨证取穴(43.9%)高于非辨证取穴(38.0%)。结论目前证据尚不能完全支持辨证针刺治疗原发性失眠优于非辨证针刺治疗。虽然在匹配的研究中观察到统计上显著的大效应量,但由于方法学的局限性、异质性和分析方法的结果不一致,这种差异的临床相关性仍然不确定。未来的试验需要直接比较和标准化的结果测量来阐明针灸治疗中辨证的临床应用。
{"title":"Is traditional Chinese medicine syndrome differentiation important in primary insomnia? An exploratory review with matching recombination indirect comparisons and network meta-analysis","authors":"Guo-Dong Li ,&nbsp;Xin-Yu Hu ,&nbsp;Yi Yuan ,&nbsp;Xi-Jing Meng ,&nbsp;Le-Yan Hu ,&nbsp;Yu-Ting Huang ,&nbsp;Hui-Juan Cao","doi":"10.1016/j.eujim.2025.102515","DOIUrl":"10.1016/j.eujim.2025.102515","url":null,"abstract":"<div><h3>Introduction</h3><div>Syndrome differentiation is the primary method of Traditional Chinese Medicine (TCM) diagnosis and treatment of diseases and has become the key to the clinical development of acupuncture. However, there is a lack of supporting clinical evidence to determine the impact of syndrome differentiation on the efficacy of acupuncture treatment. Therefore, we aimed to evaluate the importance of point selection based on syndrome differentiation by re-analyzing the trials' results in treating primary insomnia with acupuncture.</div></div><div><h3>Methods</h3><div>We systematically searched 9 databases for eligible trials. Two authors extracted data independently from citations, interventions, and outcomes. Since the \"treatment acupuncture\" and \"control acupuncture\" data compared in this study were from different trials, we matched the data in a 1:1 ratio and minimized heterogeneity between the paired groups. Matching factors included age, sex ratio, and the baseline Pittsburgh Sleep Quality Index (PSQI) score. Meta-analyses were performed using Revman 5.4 software. STATA 15.0 was used for the network meta-analysis. Effect estimation presented continuous data with a standard mean difference (SMD) with a 95 % confidence interval (CI).</div></div><div><h3>Results</h3><div>We included a total of 172 trials. After matching, 19 recombinational pairs of studies were established. Meta-analysis of the 19 pairs showed that PSQI scores in the syndrome differentiation group were lower than the non-syndrome differentiation group (SMD: -0.87, 95 %CI -1.46 to -0.28, <em>P</em> = 0.004). Network meta-analysis of all included trials showed no statistical difference in acupoints selection between syndrome and non-syndrome differentiation (SMD: -0.40, 95 % CI -2.63 to 1.84). However, acupoint selection based on syndrome differentiation (43.9 %) ranks higher than acupoint selection based on non-syndrome differentiation (38.0 %) according to SUCRA curves.</div></div><div><h3>Conclusions</h3><div>Current evidence does not conclusively support the superiority of syndrome differentiation-based acupuncture over non-syndrome differentiation for primary insomnia. While statistically significant large effect size was observed in matched studies, the clinical relevance of this difference remains uncertain due to methodological limitations, heterogeneity, and inconsistent findings across analytical approaches. Future trials with direct comparisons and standardized outcome measures are needed to clarify the clinical utility of syndrome differentiation in acupuncture therapy.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102515"},"PeriodicalIF":1.9,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes of parents and primary care practitioners towards natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections and an NMP App: results from an online survey 家长和初级保健从业人员对用于急性、无并发症上呼吸道感染的天然药物(NMP)和NMP应用程序的态度:来自在线调查的结果
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-16 DOI: 10.1016/j.eujim.2025.102514
E. Belt-van Zoen , L. Veldman , N. van Steenbergen , M. Nieuwdorp , E. Baars

Introduction

Resistance to antibiotics is an increasing worldwide problem. Hence, identifying and implementing the use of alternatives to antibiotics is crucial. A prototype app providing evidence-based advice on the use of safe and effective natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections (URTIs) is being developed. This study investigates the acceptability of NMPs (for URTIs) and the idea of an NMP app among intended end-users.

Methods

An online survey was completed by parents (n = 103), general practitioners (GP; n = 110), nurse practitioners (n = 65), physician assistants (n = 65), and pharmacists (n = 71) working in Dutch primary care.

Results

The majority of parents (66–79 %) and professionals (40–98 %) reported past use, current recommendation, or future willingness to use NMPs for URTIs. The majority of respondents (73–82 %) indicated they would use or recommend an NMP app, with main reasons being convenience, practicality, and time-saving. Most important prerequisites for use were safety and effectiveness of the included NMPs. Pharmacists reported they would use an NMP app primarily for professional development and shared decision-making (both 53 %), whereas 72 % of parents and up to 57 % of other professionals would use it mainly to support self-management. Up to 61 % of respondents expected a reduction in antibiotic use, and up to 70 % anticipated fewer primary care visits for URTIs with the introduction of an NMP App.

Conclusions

This study indicates broad acceptance of NMPs for URTIs across intended end-user groups. An NMP app seems to be a well-supported tool for reducing antibiotic use and primary care visits for children with URTIs in Dutch primary care. However, a website or web-based tool may be more fitting than a standalone mobile application. Furthermore, to prevent the exacerbation of health inequalities, it is important to also develop tools that are accessible to parents with low (health) literacy and a lower socio-economic position. GP assistants and pharmacy assistants appear key end-users for further research and implementation.
抗生素耐药性是一个日益严重的世界性问题。因此,确定和实施抗生素替代品的使用至关重要。正在开发一个原型应用程序,为使用安全有效的天然药物(nmp)治疗急性无并发症上呼吸道感染(URTIs)提供循证建议。本研究调查了NMP(用于URTIs)的可接受性以及NMP应用程序在预期最终用户中的想法。方法对103名家长(n = 103)、全科医生(GP;n = 110),执业护士(n = 65),医师助理(n = 65)和药剂师(n = 71)在荷兰初级保健工作。结果大多数家长(66 - 79%)和专业人员(40 - 98%)报告了过去使用、目前推荐或未来愿意使用nmp治疗尿路感染。大多数受访者(73 - 82%)表示他们会使用或推荐NMP应用程序,主要原因是方便、实用和节省时间。使用最重要的先决条件是所纳入nmp的安全性和有效性。药剂师报告说,他们使用NMP应用程序主要是为了专业发展和共同决策(均为53%),而72%的父母和高达57%的其他专业人员主要使用它来支持自我管理。高达61%的受访者预计,随着NMP应用程序的引入,抗生素的使用将减少,高达70%的受访者预计,URTIs的初级保健就诊将减少。结论:本研究表明,NMP在预期的最终用户群体中被广泛接受。NMP应用程序似乎是一个得到良好支持的工具,可以减少荷兰初级保健中患有尿路感染的儿童的抗生素使用和初级保健就诊。然而,一个网站或基于web的工具可能比一个独立的移动应用程序更合适。此外,为了防止保健不平等的加剧,还必须开发工具,使(保健)知识普及程度低和社会经济地位较低的父母也能使用。全科医生助理和药房助理是进一步研究和实施的关键终端用户。
{"title":"Attitudes of parents and primary care practitioners towards natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections and an NMP App: results from an online survey","authors":"E. Belt-van Zoen ,&nbsp;L. Veldman ,&nbsp;N. van Steenbergen ,&nbsp;M. Nieuwdorp ,&nbsp;E. Baars","doi":"10.1016/j.eujim.2025.102514","DOIUrl":"10.1016/j.eujim.2025.102514","url":null,"abstract":"<div><h3>Introduction</h3><div>Resistance to antibiotics is an increasing worldwide problem. Hence, identifying and implementing the use of alternatives to antibiotics is crucial. A prototype app providing evidence-based advice on the use of safe and effective natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections (URTIs) is being developed. This study investigates the acceptability of NMPs (for URTIs) and the idea of an NMP app among intended end-users.</div></div><div><h3>Methods</h3><div>An online survey was completed by parents (<em>n</em> = 103), general practitioners (GP; <em>n</em> = 110), nurse practitioners (<em>n</em> = 65), physician assistants (<em>n</em> = 65), and pharmacists (<em>n</em> = 71) working in Dutch primary care.</div></div><div><h3>Results</h3><div>The majority of parents (66–79 %) and professionals (40–98 %) reported past use, current recommendation, or future willingness to use NMPs for URTIs. The majority of respondents (73–82 %) indicated they would use or recommend an NMP app, with main reasons being convenience, practicality, and time-saving. Most important prerequisites for use were safety and effectiveness of the included NMPs. Pharmacists reported they would use an NMP app primarily for professional development and shared decision-making (both 53 %), whereas 72 % of parents and up to 57 % of other professionals would use it mainly to support self-management. Up to 61 % of respondents expected a reduction in antibiotic use, and up to 70 % anticipated fewer primary care visits for URTIs with the introduction of an NMP App.</div></div><div><h3>Conclusions</h3><div>This study indicates broad acceptance of NMPs for URTIs across intended end-user groups. An NMP app seems to be a well-supported tool for reducing antibiotic use and primary care visits for children with URTIs in Dutch primary care. However, a website or web-based tool may be more fitting than a standalone mobile application. Furthermore, to prevent the exacerbation of health inequalities, it is important to also develop tools that are accessible to parents with low (health) literacy and a lower socio-economic position. GP assistants and pharmacy assistants appear key end-users for further research and implementation.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102514"},"PeriodicalIF":1.9,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution of propolis research: A bibliometric analysis 蜂胶研究的演变:文献计量学分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-14 DOI: 10.1016/j.eujim.2025.102518
Tuğba Nigar Bozkuş

Introduction

Propolis is garnering increasing scientific and commercial interest due to its potential health benefits. Despite a surge in publications, a comprehensive overview of the propolis research landscape using bibliometric methods has been absent. This study aims to fill this gap by providing the first dedicated bibliometric analysis of global propolis research trends over the past two decades.

Methods

Data on propolis-related publications from 2004 to 2023 were retrieved from the Web of Science database. The R Bibliometrix package was employed to analyze publication trends, citation patterns, leading authors, institutions, countries, keyword co-occurrence, research themes, and collaboration networks.

Results

The analysis confirmed a substantial and consistent growth in propolis research. While publication volume is geographically concentrated (led by Brazil, China, Turkey), citation impact analysis revealed different patterns, with some countries (USA, Japan, Portugal, Bulgaria) demonstrating higher average citations per article, suggesting potential leadership in research quality or visibility. Thematic evolution mapping showed a clear trajectory from foundational studies focused on chemical composition and broad in vitro antioxidant/antimicrobial activity towards more sophisticated investigations into specific mechanisms (apoptosis, oxidative stress pathways), distinct propolis types (Brazilian green, stingless bee), and advanced applications (nanoparticles, nanofibers). Analysis identified central ‘’motor themes’’ (like chemical composition) requiring further development despite high interest, alongside highly developed ‘’niche themes’’ (like oxidative stress). Collaboration networks highlighted strong regional clusters but also opportunities for enhancing global integration, particularly bridging high-volume research hubs with high-impact centers.

Conclusion

This bibliometric analysis reveals propolis research as a dynamic, rapidly maturing, and increasingly interdisciplinary field. The divergence between publication quantity and citation impact, the clear evolution of research themes towards mechanistic depth, and the identification of specific developmental needs within the thematic structure offer critical strategic insights. The findings underscore a significant gap between the extensive preclinical investigation of biological activities of propolis and its translation into validated clinical applications. The findings advocate focused efforts on standardization, targeted international collaborations to leverage complementary strengths, and prioritizing clinical trials to substantiate the therapeutic potential suggested by the vast body of existing literature. This analysis provides an evidence-based roadmap to guide future research investments and collaborations effectively.
蜂胶由于其潜在的健康益处而获得越来越多的科学和商业兴趣。尽管出版物激增,蜂胶研究景观使用文献计量学方法的全面概述一直缺席。本研究旨在填补这一空白,提供了第一个专门的文献计量分析全球蜂胶研究趋势在过去的二十年。方法从Web of Science数据库中检索2004 - 2023年蜂胶相关文献资料。使用R Bibliometrix软件包分析出版趋势、引文模式、主要作者、机构、国家、关键词共现、研究主题和合作网络。结果分析证实了蜂胶研究的实质性和持续性增长。虽然出版物数量在地理上集中(以巴西、中国、土耳其为首),但引用影响分析显示出不同的模式,一些国家(美国、日本、葡萄牙、保加利亚)的每篇文章的平均引用率更高,表明在研究质量或知名度方面可能处于领先地位。主题进化图谱显示了清晰的轨迹,从专注于化学成分和广泛的体外抗氧化/抗菌活性的基础研究,到更复杂的特定机制(细胞凋亡、氧化应激途径)、不同蜂胶类型(巴西绿蜂胶、无刺蜂)和高级应用(纳米颗粒、纳米纤维)的研究。分析确定了需要进一步开发的核心“运动主题”(如化学成分),尽管人们对此很感兴趣,以及高度发达的“利基主题”(如氧化应激)。合作网络突出了强大的区域集群,但也为加强全球一体化提供了机会,特别是将高容量研究中心与高影响力中心连接起来。结论文献计量学分析表明蜂胶研究是一个动态的、迅速成熟的、跨学科的研究领域。出版物数量和引用影响之间的差异,研究主题向机制深度的明确演变,以及主题结构中特定发展需求的确定提供了关键的战略见解。这些发现强调了蜂胶生物活性的广泛临床前研究与其转化为有效的临床应用之间的重大差距。研究结果主张集中精力进行标准化,有针对性的国际合作,以利用互补优势,并优先进行临床试验,以证实大量现有文献所建议的治疗潜力。该分析提供了一个基于证据的路线图,以有效地指导未来的研究投资和合作。
{"title":"The evolution of propolis research: A bibliometric analysis","authors":"Tuğba Nigar Bozkuş","doi":"10.1016/j.eujim.2025.102518","DOIUrl":"10.1016/j.eujim.2025.102518","url":null,"abstract":"<div><h3>Introduction</h3><div>Propolis is garnering increasing scientific and commercial interest due to its potential health benefits. Despite a surge in publications, a comprehensive overview of the propolis research landscape using bibliometric methods has been absent. This study aims to fill this gap by providing the first dedicated bibliometric analysis of global propolis research trends over the past two decades.</div></div><div><h3>Methods</h3><div>Data on propolis-related publications from 2004 to 2023 were retrieved from the Web of Science database. The R Bibliometrix package was employed to analyze publication trends, citation patterns, leading authors, institutions, countries, keyword co-occurrence, research themes, and collaboration networks.</div></div><div><h3>Results</h3><div>The analysis confirmed a substantial and consistent growth in propolis research. While publication volume is geographically concentrated (led by Brazil, China, Turkey), citation impact analysis revealed different patterns, with some countries (USA, Japan, Portugal, Bulgaria) demonstrating higher average citations per article, suggesting potential leadership in research quality or visibility. Thematic evolution mapping showed a clear trajectory from foundational studies focused on chemical composition and broad in vitro antioxidant/antimicrobial activity towards more sophisticated investigations into specific mechanisms (apoptosis, oxidative stress pathways), distinct propolis types (Brazilian green, stingless bee), and advanced applications (nanoparticles, nanofibers). Analysis identified central ‘’motor themes’’ (like chemical composition) requiring further development despite high interest, alongside highly developed ‘’niche themes’’ (like oxidative stress). Collaboration networks highlighted strong regional clusters but also opportunities for enhancing global integration, particularly bridging high-volume research hubs with high-impact centers.</div></div><div><h3>Conclusion</h3><div>This bibliometric analysis reveals propolis research as a dynamic, rapidly maturing, and increasingly interdisciplinary field. The divergence between publication quantity and citation impact, the clear evolution of research themes towards mechanistic depth, and the identification of specific developmental needs within the thematic structure offer critical strategic insights. The findings underscore a significant gap between the extensive preclinical investigation of biological activities of propolis and its translation into validated clinical applications. The findings advocate focused efforts on standardization, targeted international collaborations to leverage complementary strengths, and prioritizing clinical trials to substantiate the therapeutic potential suggested by the vast body of existing literature. This analysis provides an evidence-based roadmap to guide future research investments and collaborations effectively.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102518"},"PeriodicalIF":1.9,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and acceptability of a yoga-based mind body intervention for women with a history of hypertensive disorder in pregnancy 以瑜伽为基础的身心干预对妊娠期高血压病史妇女的可行性和可接受性
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-14 DOI: 10.1016/j.eujim.2025.102499
Caroline A Smith , Kylie Barr , Angela Makris , Amanda Henry , Hannah Dahlen , Annemarie Hennessy , Alison Canty , Wendy Pickup

Introduction

Hypertensive disorders of pregnancy affect 5 to 10% of women and are a significant cause of perinatal morbidity and mortality. This group of women have been shown to have an elevated risk of cardiovascular disease (CVD) and premature mortality. There are currently no interventions specifically targeting this at-risk group of women to reduce relevant risk factors and improve outcomes. In other populations of individuals at high CVD risk, studies suggest yoga may be effective in reducing CVD risk. This study examined the feasibility of yoga in contributing to the management of blood pressure postpartum.

Methods

A feasibility study was conducted. The primary objective was to examine recruitment, adherence, satisfaction, and safety of the yoga intervention. Secondary objectives included change in blood pressure, serological measures, quality of life and anxiety. Women were eligible from five to seven months postpartum. An online yoga intervention was delivered over eight weeks.

Results

Ten women (16% of those eligible) were recruited. All women completed the intervention. Compliance with the clinical outcome assessments ranged between 70 and 90%. There was high fidelity with intervention engagement. There were no significant changes over time in any clinical outcome, although a trend to overall improved quality of life (p=0.06) was seen. There were no adverse reactions reported.

Conclusion

Although uptake was low, women engaged well with postpartum yoga. Further research on yoga is needed to test effectiveness for CVD risk reduction for women with hypertension in the postpartum setting, involving an appropriately powered randomised controlled trial. The study was registered with the Australian and New Zealand Clinical Trial Registry (Registration number ACTRN: 12622000450718).
妊娠期高血压疾病影响5%至10%的妇女,是围产期发病率和死亡率的重要原因。这组妇女患心血管疾病(CVD)和过早死亡的风险较高。目前还没有专门针对这一高危妇女群体的干预措施来减少相关风险因素和改善结果。在其他心血管疾病高风险人群中,研究表明瑜伽可能有效降低心血管疾病风险。本研究探讨了瑜伽对产后血压管理的可行性。方法进行可行性研究。主要目的是检查瑜伽干预的招募、依从性、满意度和安全性。次要目标包括血压、血清学指标、生活质量和焦虑的变化。妇女在产后5到7个月有资格。在线瑜伽干预持续了八周。结果共招募了10名女性(占符合条件的16%)。所有女性都完成了干预。临床结果评估的依从性在70%到90%之间。干预参与的保真度很高。虽然观察到总体生活质量改善的趋势(p=0.06),但随着时间的推移,任何临床结果都没有显著变化。无不良反应报告。结论虽然孕妇对产后瑜伽的接受程度较低,但她们对产后瑜伽的参与程度较高。需要进一步的研究来测试瑜伽对产后高血压妇女降低心血管疾病风险的有效性,包括适当的随机对照试验。该研究已在澳大利亚和新西兰临床试验注册中心注册(注册号ACTRN: 12622000450718)。
{"title":"Feasibility and acceptability of a yoga-based mind body intervention for women with a history of hypertensive disorder in pregnancy","authors":"Caroline A Smith ,&nbsp;Kylie Barr ,&nbsp;Angela Makris ,&nbsp;Amanda Henry ,&nbsp;Hannah Dahlen ,&nbsp;Annemarie Hennessy ,&nbsp;Alison Canty ,&nbsp;Wendy Pickup","doi":"10.1016/j.eujim.2025.102499","DOIUrl":"10.1016/j.eujim.2025.102499","url":null,"abstract":"<div><h3>Introduction</h3><div>Hypertensive disorders of pregnancy affect 5 to 10% of women and are a significant cause of perinatal morbidity and mortality. This group of women have been shown to have an elevated risk of cardiovascular disease (CVD) and premature mortality. There are currently no interventions specifically targeting this at-risk group of women to reduce relevant risk factors and improve outcomes. In other populations of individuals at high CVD risk, studies suggest yoga may be effective in reducing CVD risk. This study examined the feasibility of yoga in contributing to the management of blood pressure postpartum.</div></div><div><h3>Methods</h3><div>A feasibility study was conducted. The primary objective was to examine recruitment, adherence, satisfaction, and safety of the yoga intervention. Secondary objectives included change in blood pressure, serological measures, quality of life and anxiety. Women were eligible from five to seven months postpartum. An online yoga intervention was delivered over eight weeks.</div></div><div><h3>Results</h3><div>Ten women (16% of those eligible) were recruited. All women completed the intervention. Compliance with the clinical outcome assessments ranged between 70 and 90%. There was high fidelity with intervention engagement. There were no significant changes over time in any clinical outcome, although a trend to overall improved quality of life (p=0.06) was seen. There were no adverse reactions reported.</div></div><div><h3>Conclusion</h3><div>Although uptake was low, women engaged well with postpartum yoga. Further research on yoga is needed to test effectiveness for CVD risk reduction for women with hypertension in the postpartum setting, involving an appropriately powered randomised controlled trial. The study was registered with the Australian and New Zealand Clinical Trial Registry (Registration number ACTRN: 12622000450718).</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102499"},"PeriodicalIF":1.9,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144653321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training needs for (UK) professional standards authority accredited register and regulated traditional, complementary and integrative medicine professions for supporting patients to make lifestyle and health behaviour changes: A rapid narrative review (联合王国)专业标准管理局认可、注册和管理的传统、补充和综合医学专业人员的培训需求,以支持患者改变生活方式和健康行为:快速叙述审查
IF 1.7 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-12 DOI: 10.1016/j.eujim.2025.102517
Jonquil Pinto, Katie Read, Ella Tarabey, Felicity L. Bishop

Introduction

Improving healthy lifestyles is a public health priority. Traditional, Complementary and Integrative medicine (TCIM) providers, and certain professions on the UK Professional Standards Authority (PSA) Accredited Registers (AR) may be well-placed to contribute - some TCIM professions already support patients to make behaviour changes. We aimed to map the landscape of training for PSA AR and regulated TCIM practitioners working with individuals to support lifestyle changes, including current provision, gaps and training needs.

Methods

We conducted a rapid narrative review of training within PSA AR and regulated TCIM professions. We searched research databases for articles exploring perceptions, experiences and responses to training (for supporting behaviour change) and searched websites of UK professional bodies for educational guidelines for pre-qualification education. We conducted systematic data searching and extraction, quality appraisal and produced a narrative synthesis of research and guidelines which identified patterns across professions.

Results

We identified 24 education guidelines (4 were unlocated). A total of 548 research studies were identified from database searches, and we identified 5 further studies. A total of 20 full-text articles were retrieved, 7 were excluded, leaving 13 in the review. While 22 of 24 guidelines mentioned lifestyle or health behaviour, only 4 (chiropractic, nutritional therapy, osteopathy and acupuncture) provided any detailed recommendations about how to support patients to make health behaviour changes (e.g. providing written information or recording/monitoring progress). Eight of the 13 research studies focussed on chiropractic; most studies focussed on physical activity, two on smoking cessation, and several looked at training in broad techniques including motivational interviewing. Practitioners in research studies were generally positive about training in lifestyle and health behaviour change and there was some evidence that such training enhances practitioner self-efficacy or skills.

Conclusions

Most evidence of engagement with supporting lifestyle/behaviour change is within four professions: chiropractic, osteopathy, nutritional therapy and acupuncture. To build on existing knowledge and practice, future training for chiropractors, osteopaths, nutritional therapists and acupuncturists could target the capabilities (e.g. knowledge, skills, decision-making), opportunities (e.g. resources) and motivations (e.g. social/professional role) of practitioners. Future research should also evaluate the impact of practitioner training on patients’ lifestyle and health behaviours.
改善健康的生活方式是公共卫生的优先事项。传统、补充和综合医学(TCIM)提供者以及英国专业标准局(PSA)认可登记册(AR)上的某些专业可能会做出很好的贡献——一些TCIM专业已经支持患者做出行为改变。我们的目标是绘制PSA AR和受监管的TCIM从业人员与个人合作以支持生活方式改变的培训景观,包括目前的供应,差距和培训需求。方法我们对PSA AR和受监管的TCIM专业人员的培训进行了快速回顾。我们在研究数据库中搜索了探讨对培训(支持行为改变)的看法、经验和反应的文章,并在英国专业机构的网站上搜索了资格预审教育的教育指南。我们进行了系统的数据搜索和提取,质量评估,并产生了一个研究的叙述性综合和指导方针,以确定跨专业的模式。结果我们确定了24条教育指南(其中4条没有定位)。从数据库检索中共确定了548项研究,我们确定了5项进一步的研究。共检索到20篇全文文章,排除7篇,纳入综述13篇。虽然24项指南中有22项提到了生活方式或健康行为,但只有4项(脊椎指压疗法、营养疗法、整骨疗法和针灸)提供了关于如何支持患者改变健康行为的详细建议(例如提供书面信息或记录/监测进展)。13项研究中有8项关注脊椎指压疗法;大多数研究关注的是体育锻炼,两项研究关注的是戒烟,还有几项研究关注的是包括动机性访谈在内的广泛技术培训。研究中的从业人员对改变生活方式和健康行为的培训普遍持积极态度,有一些证据表明,这种培训提高了从业人员的自我效能或技能。结论:大多数支持生活方式/行为改变的证据来自四个专业:脊椎指压疗法、整骨疗法、营养疗法和针灸。在现有知识和实践的基础上,未来对脊医、整骨治疗师、营养治疗师和针灸师的培训可以针对从业者的能力(如知识、技能、决策)、机会(如资源)和动机(如社会/专业角色)。未来的研究还应评估从业人员培训对患者生活方式和健康行为的影响。
{"title":"Training needs for (UK) professional standards authority accredited register and regulated traditional, complementary and integrative medicine professions for supporting patients to make lifestyle and health behaviour changes: A rapid narrative review","authors":"Jonquil Pinto,&nbsp;Katie Read,&nbsp;Ella Tarabey,&nbsp;Felicity L. Bishop","doi":"10.1016/j.eujim.2025.102517","DOIUrl":"10.1016/j.eujim.2025.102517","url":null,"abstract":"<div><h3>Introduction</h3><div>Improving healthy lifestyles is a public health priority. Traditional, Complementary and Integrative medicine (TCIM) providers, and certain professions on the UK Professional Standards Authority (PSA) Accredited Registers (AR) may be well-placed to contribute - some TCIM professions already support patients to make behaviour changes. We aimed to map the landscape of training for PSA AR and regulated TCIM practitioners working with individuals to support lifestyle changes, including current provision, gaps and training needs.</div></div><div><h3>Methods</h3><div>We conducted a rapid narrative review of training within PSA AR and regulated TCIM professions. We searched research databases for articles exploring perceptions, experiences and responses to training (for supporting behaviour change) and searched websites of UK professional bodies for educational guidelines for pre-qualification education. We conducted systematic data searching and extraction, quality appraisal and produced a narrative synthesis of research and guidelines which identified patterns across professions.</div></div><div><h3>Results</h3><div>We identified 24 education guidelines (4 were unlocated). A total of 548 research studies were identified from database searches, and we identified 5 further studies. A total of 20 full-text articles were retrieved, 7 were excluded, leaving 13 in the review. While 22 of 24 guidelines mentioned lifestyle or health behaviour, only 4 (chiropractic, nutritional therapy, osteopathy and acupuncture) provided any detailed recommendations about how to support patients to make health behaviour changes (e.g. providing written information or recording/monitoring progress). Eight of the 13 research studies focussed on chiropractic; most studies focussed on physical activity, two on smoking cessation, and several looked at training in broad techniques including motivational interviewing. Practitioners in research studies were generally positive about training in lifestyle and health behaviour change and there was some evidence that such training enhances practitioner self-efficacy or skills.</div></div><div><h3>Conclusions</h3><div>Most evidence of engagement with supporting lifestyle/behaviour change is within four professions: chiropractic, osteopathy, nutritional therapy and acupuncture. To build on existing knowledge and practice, future training for chiropractors, osteopaths, nutritional therapists and acupuncturists could target the capabilities (e.g. knowledge, skills, decision-making), opportunities (e.g. resources) and motivations (e.g. social/professional role) of practitioners. Future research should also evaluate the impact of practitioner training on patients’ lifestyle and health behaviours.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102517"},"PeriodicalIF":1.7,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144772378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1